Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Tech Transfer Awards
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • NIH IRP Access Planning Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NINDS

AN ARTIFICIAL NETWORK FOR TEMPORAL PROCESSING

  • Read more about AN ARTIFICIAL NETWORK FOR TEMPORAL PROCESSING
Patent Cooperation Treaty
PCT/US1994/007007
Filed on 1994-06-24

USE OF NEURO-DERIVED FETAL CELL LINES FOR TRANSPLANTATION THERAPY

  • Read more about USE OF NEURO-DERIVED FETAL CELL LINES FOR TRANSPLANTATION THERAPY
Patent Cooperation Treaty
PCT/US1994/003938
Filed on 1994-04-11

THE PCT-65 SEROTONIN RECEPTOR

  • Read more about THE PCT-65 SEROTONIN RECEPTOR
Patent Cooperation Treaty
PCT/US1993/010301
Filed on 1993-10-26

THE St-B17 SEROTONIN RECEPTOR

  • Read more about THE St-B17 SEROTONIN RECEPTOR
Patent Cooperation Treaty
PCT/US1993/010296
Filed on 1993-10-26

METHOD OF TREATING AND PROTECTING AGAINST CENTRAL NERVOUS SYSTEM ISCHEMIA, HYPOXIA, DEGENERATION, AND TRAUMA WITH 5-AMINOCARBONYL-SH-DIBENZO[A,D]CYCLOHEPTEN-5,10-IMINE

  • Read more about METHOD OF TREATING AND PROTECTING AGAINST CENTRAL NERVOUS SYSTEM ISCHEMIA, HYPOXIA, DEGENERATION, AND TRAUMA WITH 5-AMINOCARBONYL-SH-DIBENZO[A,D]CYCLOHEPTEN-5,10-IMINE
Patent Cooperation Treaty
PCT/US1993/005845
Filed on 1993-06-16

A FAT CELL SPECIFIC β-ADRENERGIC RECEPTOR

  • Read more about A FAT CELL SPECIFIC β-ADRENERGIC RECEPTOR
Patent Cooperation Treaty
PCT/US1992/009379
Filed on 1992-10-30

ASTROCYTE-SPECIFIC TRANSCRIPTION OF HUMAN GENES

  • Read more about ASTROCYTE-SPECIFIC TRANSCRIPTION OF HUMAN GENES
Patent Cooperation Treaty
PCT/US1992/008379
Filed on 1992-10-05

TREATMENT OF ALCOHOL WITHDRAWAL SYMPTOMS

  • Read more about TREATMENT OF ALCOHOL WITHDRAWAL SYMPTOMS
Patent Cooperation Treaty
PCT/US1992/003580
Filed on 1992-05-08

A cDNA ENCODING THE RATD1 DOPAMINE RECEPTOR LINKED TO ADENYLYL CYCLASE ACTIVATION AND EXPRESSION PRODUCT

  • Read more about A cDNA ENCODING THE RATD1 DOPAMINE RECEPTOR LINKED TO ADENYLYL CYCLASE ACTIVATION AND EXPRESSION PRODUCT
Patent Cooperation Treaty
PCT/US1991/004721
Filed on 1991-07-02

CLONED GENES FOR HUMAN DOPAMINE D2 RECEPTORS AND CELL LINES EXPRESSING SAME

  • Read more about CLONED GENES FOR HUMAN DOPAMINE D2 RECEPTORS AND CELL LINES EXPRESSING SAME
Patent Cooperation Treaty
PCT/US1990/005461
Filed on 1990-09-27

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 104
  • Page 105
  • Page 106
  • Page 107
  • Page 108
  • Page 109
  • Page 110
  • Page 111
  • Page 112
  • …
  • Next page ››
  • Last page Last »
Subscribe to NINDS
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health